Presentation is loading. Please wait.

Presentation is loading. Please wait.

CORONARY CARE UNIT (CCU) Rasim ENAR, M.D. Professor of Cardiology İstabul University Cerrahpaşa Medical Faculty Department of Cardiology.

Similar presentations


Presentation on theme: "CORONARY CARE UNIT (CCU) Rasim ENAR, M.D. Professor of Cardiology İstabul University Cerrahpaşa Medical Faculty Department of Cardiology."— Presentation transcript:

1 CORONARY CARE UNIT (CCU) Rasim ENAR, M.D. Professor of Cardiology İstabul University Cerrahpaşa Medical Faculty Department of Cardiology

2 Intensive Care Units Development of the Concept Intensive Care Units Development of the Concept *Post-World War II era; *Post-World War II era; Intensive Care Unıts (General, Surgical, New-born, etc..) (ICU..). Intensive Care Unıts (General, Surgical, New-born, etc..) (ICU..). *1961; (Desmond Julian); Cardiac Care Unıt and CCU was first mentioned *1961; (Desmond Julian); Cardiac Care Unıt and CCU was first mentioned

3 …INTENSIVE CARE….!!!?

4 ICU - Definition: Monitorization of vital parameters ( blood presure, respiration, pulse rate, temperature, hydration, electrolyte, blood gas, etc) and systemic organ functions (heart, brain, lungs, kidneys, liver) in a multi-disiplinary approach, AND maintaining those parameters in normal (physiological – healthy) limits. Monitorization of vital parameters ( blood presure, respiration, pulse rate, temperature, hydration, electrolyte, blood gas, etc) and systemic organ functions (heart, brain, lungs, kidneys, liver) in a multi-disiplinary approach, AND maintaining those parameters in normal (physiological – healthy) limits.

5 Ideal CCU Environment Well-trained staff (Physician, nurse, technician) Well-trained staff (Physician, nurse, technician) Advanced ECG and hemodyanamic monitorization equipment (bed-side and central and print-out) Advanced ECG and hemodyanamic monitorization equipment (bed-side and central and print-out) Hemodynamic support devices (IABP, temporary pace-maker) Hemodynamic support devices (IABP, temporary pace-maker) Mechanical ventilation devices Mechanical ventilation devices Bed-side laboratory examination (Biomarkers, CBC, BUN, Crea, Electrolyte, etc) Bed-side laboratory examination (Biomarkers, CBC, BUN, Crea, Electrolyte, etc) Portable Imaging (X-Ray and Echocardiograpy) Portable Imaging (X-Ray and Echocardiograpy) Effective CPR organization Effective CPR organization

6 CCU Admitance Indications Acute coronary syndromes and complications Acute coronary syndromes and complications Monitorization of serious arrhythmias Monitorization of serious arrhythmias Acute cardiac emergiencies ( acute pulmonary edema,severe hypotensıon, shock, hypertensive crisis). Acute cardiac emergiencies ( acute pulmonary edema,severe hypotensıon, shock, hypertensive crisis). Cardiogenic shock. Cardiogenic shock. High risk PCI. High risk PCI. Post-cardiac surgery; hemodynamic instability and recurrent ischemia and malign arrhythmia. Post-cardiac surgery; hemodynamic instability and recurrent ischemia and malign arrhythmia. Post-CPR monitorization. Post-CPR monitorization.

7 CCU and Acute Coronary Syndomes: CCU : LIFE SAVING UNITS -GOLD STANDART for the management of STE- AMI, and High-Intermediate risk NSTE-ACS, and their complications (Mainstay of therapy). CCU : LIFE SAVING UNITS -GOLD STANDART for the management of STE- AMI, and High-Intermediate risk NSTE-ACS, and their complications (Mainstay of therapy). STE- AMI: STE- AMI: (a) (a) Assessment of thrombolysis and reperfusion. (b) Treatment of Sudden Cardiac Death and arrhythmic death (Defibrillation, PM). (c) Early and rescue PCI. (c) Early and rescue PCI. (d) Early diagnosis and management of mechanical complications. (d) Early diagnosis and management of mechanical complications.

8 NSTEMI / USAP; FATAL/NONFATAL-MI RISC High Risc : () cTnT/I, ST dep (new ?). () cTnT/I, ST dep (new ?). Refracter ischemia despite maksimal anti-ischemic medical therapy. Refracter ischemia despite maksimal anti-ischemic medical therapy. Heart failure. Heart failure. (+) Noninvasive, stress- test : LV fuction (EF<%40). (+) Noninvasive, stress- test : LV fuction (EF<%40). - Incessant, recurrent VT. Previous PCI (in last 6 months) or CABG. Previous PCI (in last 6 months) or CABG. Intermediate Risc: Intermediate Risc: Chest pain > 10 min but relieved at enterance of ED. Chest pain > 10 min but relieved at enterance of ED. Negative T-waves >2 mm. Negative T-waves >2 mm. mild cTnT (>0.01, 0.01,<0.1 ng/ml).

9 * CCU- NSTE ACS: Mortality and non-fatal MI risc in 35 days was significantly reduced in high and moderate risc patientsi Other Spesific clinical indications for CCU: Other Spesific clinical indications for CCU: (a) Persistant and recurrent ischemia with hemodynamic instability (Cardiogenic shock, left heart failure, hypotension). (b) Refractory angina. (c) Malign arrhythmia with hemodynamic instability (d) Reccurrent angina. (e) Early and urgent coronary angiography and and coronary revascularization if it is indicated.

10 CCU: Hemodynamic Monitorization and Supportive Therapies 1. (a) Pulmonary artery catheterizatıon (Swan- Ganz baloon catheter) (meadurement of PCWP, right heart pressures,and estimate CO, CI). 1. (a) Pulmonary artery catheterizatıon (Swan- Ganz baloon catheter) (meadurement of PCWP, right heart pressures,and estimate CO, CI). (b) Intra-arterial catheter (for continious arteriei pressure measurement). (b) Intra-arterial catheter (for continious arteriei pressure measurement). (c) Pulse- oximetry. (c) Pulse- oximetry. 2. IABP (Intra-aortik Baloon Pump) 2. IABP (Intra-aortik Baloon Pump) 3. Hemofiltration (UF). 3. Hemofiltration (UF). 4. Temporary Pace- maker. 4. Temporary Pace- maker. 5. Mechanical ventilatıon. 5. Mechanical ventilatıon.

11 İndicatıon of Hemodyanamic Evaluation in AMI: Pulmonary artery catheter (Swan-Ganz) monitoring. Pulmonary artery catheter (Swan-Ganz) monitoring. 1- Progressive hypotension (++). 2- Suspected mechanical complications (if an echocardiography has not been provided) (+). 3- Progessive hypotension; unresponsive to fluid administration or when fluid administration is contraindicated (±). 4- Cardiogenic shock (±). 5- Severe or progressive CHF or pulmonary edema that does not respond rapidly to therapy (±). 6- Persistent signs of hypoperfusion without hypotension or pulmonary congestion (±).

12 INTENSIVE CARE INTENSIVE CARE

13

14

15 Swan-Ganz Catheter; Baloon- tipped Pulmonary artery catheterizatıon

16 Localization of Swan- Ganz Catheter (Chest radiograph)

17 Swan-Ganz Catheter; Right heart pressures: Right- atrium, Right- ventricule, Pulmonary artery and Pulmonary capillary wedge pressure (ocluded PA pressure):

18 İndicatıons of Intra-arterial pressure monitorization in AMI * Most life treatening complications in the acute phase of AMI is hypotension; it is the most important andindependent predictor of mortality 1- Severe systolic hypotension (<80 mmHg) (++) 1- Severe systolic hypotension (<80 mmHg) (++) 2- Cardiogenic shock (++). 2- Cardiogenic shock (++). 3- Patients receiving vasopressor / inotropic agents 3- Patients receiving vasopressor / inotropic agents (+/±). (+/±). 4- Patients receiving intravenous potent Nitroodilator agents (±). 4- Patients receiving intravenous potent Nitroodilator agents (±).

19 IABP Indications in AMI 1- Persistent hypotension (sistolik blood pressure 30 mmHg drop in baseline blood pressure) despite standart pharmacologic therapy) (++) 2- Low-output patients (+) 3- In patients when cardiogenic shock is not quickly reversed with pharmacologic therapy (++) 4- In patients with hemodynamic instability prior to early PCI / revascularization (+). 5- Mechanical complications ( MR,VSR) as a bridge to cardiac surgery (++). 6- Reccurrent ischemic complaints (large MI, unstable hemodynamic state, LV disfunction) (±).

20 IABP LOCALISATION

21

22

23 AMI - Mechanical Ventilation Major Indications: Major Indications: Acute hypoksemic respiratory failure despite continous supplemental oxygen therapy ( 4-6 Lt/min O2 therapy with nasal prolongs for 2-3 hours). Acute hypoksemic respiratory failure despite continous supplemental oxygen therapy ( 4-6 Lt/min O2 therapy with nasal prolongs for 2-3 hours). * PaO2 60 mmHg. * PaO2 60 mmHg. O2 satüration<%90. O2 satüration<%90. Clinical States : Clinical States : (a) Cardiogenic pulmonary edema, Cardiogenic shock (a) Cardiogenic pulmonary edema, Cardiogenic shock (b) Cardiopulmonary arrest (pulseless arrhythmia and rhythm disturbances ;VT,VF,EM dissociation) (b) Cardiopulmonary arrest (pulseless arrhythmia and rhythm disturbances ;VT,VF,EM dissociation) (c) Cerebrovascular accident (cerebral emboli / hemorrage, and coma) (c) Cerebrovascular accident (cerebral emboli / hemorrage, and coma)

24

25

26 INTENSIVE CARE; Patient monitorization and treatment..!!

27 CCU treatment goals in Acute STEMI Patients 1- Aspirin should be chewed by patients on presentation. 2- Beta-blocker therapy should be given on presentation (IV is preferred) and continuing at discharge for indefinitly. 3- Discharge medication will include Aspirin,ACEİ,BBl,Statin. 4- ACE-I or ARB to pts with low LVEF (<%40). 5- Convincing patient to quit cigarette smoking. 6- IV Fibrinolysis; Door-needle time: mean 30 minutes (preferably 30 min) 7- Primary PCI; Door- Balloon time: minutes (preferably 90 min) 8- Thrombolysis or primary PCI in %75 of patients with acute reperfusion indication 9- İn Hospital mortality sholud be less than %7-10 in hospitilized patients.


Download ppt "CORONARY CARE UNIT (CCU) Rasim ENAR, M.D. Professor of Cardiology İstabul University Cerrahpaşa Medical Faculty Department of Cardiology."

Similar presentations


Ads by Google